Asia Pacific Ultrasound Market Outlook (2021-2031)

The Asia Pacific ultrasound market is projected to grow significantly, reaching an estimated US$ 1,252.20 million by 2031, up from US$ 827.66 million in 2024. This growth represents a compound annual growth rate (CAGR) of 6.2% from 2025 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as one of the most vibrant and rapidly expanding areas in the global ultrasound market. This growth is driven by a combination of advanced economies and emerging healthcare systems. Key factors contributing to this expansion include the increasing demand for less invasive diagnostic imaging, heightened healthcare investments, and a rising burden of chronic diseases.

China stands out as the market leader, benefiting from extensive infrastructure development, robust domestic manufacturing capabilities, and a wide range of clinical applications. Other significant contributors to the market include Japan, South Korea, and Australia, which are equipped with advanced imaging technologies and operate under well-established regulatory frameworks. Additionally, emerging markets like India and Vietnam are experiencing a surge in the adoption of portable and point-of-care ultrasound systems. The diverse healthcare access and policies across the region present both challenges and opportunities. Nonetheless, ultrasound technology is becoming a standard diagnostic tool across various clinical specialties. With a growing emphasis on early detection as a preventive healthcare strategy, the utilization of ultrasound is expected to enhance diagnostic access and improve clinical outcomes for many patients in the region.

Market Segmentation Analysis

The ultrasound market can be segmented based on product type, portability, application, and end user.

Product Type: The market is divided into diagnostic ultrasound systems and therapeutic ultrasound systems, with diagnostic systems dominating the market in 2024.
Portability: Ultrasound devices are categorized into portable/trolley-based devices and handheld devices, with the former leading the market in 2024.
Application: The market is segmented into various applications, including general imaging, cardiology, oncology, gynecology, orthopedics, urology, gastroenterology, and others. The general imaging segment was the largest in 2024.
End User: The end-user segmentation includes hospitals, specialty clinics, diagnostic imaging centers, ambulatory surgical centers, and others, with hospitals holding the largest market share in 2024.

Market Outlook

The ultrasound market in the Asia Pacific region is shaped by demographic trends, rapid technological advancements, and evolving healthcare priorities. Its widespread application in fields such as obstetrics, cardiology, emergency care, and oncology underscores its importance as a diagnostic tool in both advanced hospitals and resource-limited clinics. A significant driver of market growth is the increasing localization of ultrasound manufacturing, particularly in China.

Domestic manufacturers are producing imaging systems that not only meet but often exceed international quality standards, all while reducing costs and delivery times. This localization is enhancing access to advanced technologies across both public and private healthcare sectors in the region. Furthermore, supportive government policies are fostering indigenous innovation and decreasing reliance on imported technologies. The integration of artificial intelligence into ultrasound platforms is also enhancing diagnostic capabilities and streamlining workflows. As healthcare systems in the Asia Pacific continue to expand and modernize, ultrasound remains a scalable and cost-effective solution for improving diagnostic reach and patient care.

Country Insights

The Asia Pacific ultrasound market is further analyzed by country, including China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and others. China is the dominant player in the market as of 2024.

China's leadership in the ultrasound market is attributed to its extensive healthcare network, strong domestic manufacturing, and favorable government policies. Ultrasound imaging is widely utilized in hospitals, specialty centers, and rural clinics for various applications, including maternal health, cancer detection, cardiac care, and emergency services. The country's commitment to enhancing healthcare accessibility has led to a significant increase in the use of portable ultrasound systems, particularly in underserved areas. Chinese companies, such as Mindray, are pivotal in this growth, producing affordable and high-quality devices tailored to local needs.

Moreover, China's regulatory environment facilitates the rapid adoption of new technologies, including AI-enhanced imaging and tele-ultrasound solutions. The integration of ultrasound into national health initiatives and the expansion of private healthcare providers further stimulate market growth. With its combination of a large consumer base, technological innovation, and government support, China is poised to remain a leader in the Asia Pacific ultrasound market.

Company Profiles

Key players in the Asia Pacific ultrasound market include GE HealthCare, Siemens Healthineers AG, FUJIFILM Holdings Corporation, Canon Inc., Koninklijke Philips N.V., Esaote SPA, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic Inc., Trivitron Healthcare, and Samsung Healthcare. These companies employ strategies such as market expansion, product innovation, and mergers and acquisitions to maintain competitiveness and deliver cutting-edge products to consumers. Show more